Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. is a registered legal entity registered in United States, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 30 April 2026 and lists its registered address as Cranbury, United States. 4 shareholders are on record for Rocket Pharmaceuticals, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 25 September 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Shareholders of Rocket Pharmaceuticals, Inc.
Four shareholders are currently on record for Rocket Pharmaceuticals, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 11.5% — the largest recorded stake — followed by Vanguard Explorer Fund at 1.3%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 11.5% | New Jersey Division of Revenue & Enterprise Services | |
| Vanguard Explorer Fund | 1.3% | New Jersey Division of Revenue & Enterprise Services | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.2% | New Jersey Division of Revenue & Enterprise Services | |
| iShares Trust-iShares Russell 2000 Value ETF | 0.8% | New Jersey Division of Revenue & Enterprise Services |
Officers
16
Directors and officers of Rocket Pharmaceuticals, Inc.
The Ceo & Director of Rocket Pharmaceuticals, Inc. currently on record is Gaurav D. Shah M.d.; 16 officers are currently on record for Rocket Pharmaceuticals, Inc., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at Rocket Pharmaceuticals, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Group structure of Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
- Rocket Pharmaceuticals, Ltd. (United States)
- Renovacor, Inc. (United States)
- Rocket Foundation, Inc. (United States)
- Rocket Pharmaceuticals B.V. (Netherlands)
- Inotek Securities Corporation (United States)
Data availability
Those 5 subsidiaries span United States, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 5 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Rocket Pharmaceuticals, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Rocket Pharmaceuticals, Inc.?
Four shareholders are currently on record for Rocket Pharmaceuticals, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 11.5% — the largest recorded stake — followed by Vanguard Explorer Fund at 1.3%; the remaining 2 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Rocket Pharmaceuticals, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Rocket Pharmaceuticals, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Rocket Pharmaceuticals, Inc. have on record?
4 shareholders are shown on record for Rocket Pharmaceuticals, Inc..
Is Rocket Pharmaceuticals, Inc. still an active company?
Rocket Pharmaceuticals, Inc.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.
When was Rocket Pharmaceuticals, Inc. incorporated?
Rocket Pharmaceuticals, Inc. was incorporated on 30 April 2026, according to New Jersey Division of Revenue & Enterprise Services.
What is Rocket Pharmaceuticals, Inc.'s registered address?
The registered address on file for Rocket Pharmaceuticals, Inc. is Cranbury, United States.
Who are the officers/directors of Rocket Pharmaceuticals, Inc.?
The Ceo & Director of Rocket Pharmaceuticals, Inc. currently on record is Gaurav D. Shah M.d.; 16 officers are currently on record for Rocket Pharmaceuticals, Inc., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at Rocket Pharmaceuticals, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Rocket Pharmaceuticals, Inc. have a parent company or subsidiaries?
Rocket Pharmaceuticals, Inc. has no recorded parent company — it sits at the top of its own group structure, with 5 subsidiaries recorded beneath it across 2 jurisdictions. Those 5 subsidiaries span United States, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Three of the 5 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Rocket Pharmaceuticals, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to Rocket Pharmaceuticals, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Rocket Pharmaceuticals, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Rocket Pharmaceuticals, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 25 September 2026.